user

Survival data of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected NSCLC

被引：0
|
作者：
Kenmotsu, Hirotsugu [1 ]
Ohde, Yasuhisa [2 ]
Wakuda, Kazushige [1 ]
Nakashima, Kazuhisa [1 ]
Omori, Shota [1 ]
Ono, Akira [1 ]
Naito, Tateaki [1 ]
Murakami, Haruyasu [1 ]
Endo, Masahiro [3 ]
Takahashi, Toshiaki [1 ]
机构：
[1] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka, Japan
[2] Shizuoka Canc Ctr, Div Thorac Surg, Nagaizumi, Shizuoka, Japan
[3] Shizuoka Canc Ctr, Div Diagnost Radiol, Nagaizumi, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Randomized trial of adjuvant chemotherapy (Cx) with cisplatin plus gemcitabine (CG) versus cisplatin plus docetaxel (CD) in patients (pts) with completely resected non-small cell lung cancer (NSCLC) with quality of life (QoL) as the primary objective
    Barlesi, F.
    Chouaid, C.
    Crequit, J.
    Lecaer, H.
    Pujol, J.
    Berard, H.
    Vergnenegre, A.
    Letreut, J.
    Fabre-Guillevin, E.
    Loundou, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer
    Yamaguchi, Masafumi
    Takeo, Sadanori
    Suemitsu, Ryuichi
    Matsuzawa, Hironori
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 107 - 112
  • [43] Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer
    Masafumi Yamaguchi
    Sadanori Takeo
    Ryuichi Suemitsu
    Hironori Matsuzawa
    [J]. Cancer Chemotherapy and Pharmacology, 2010, 66 : 107 - 112
  • [44] Cisplatin vs carboplatin in adjuvant NSCLC chemotherapy
    Haridass, A.
    Eswar, C. V.
    Wong, H.
    [J]. LUNG CANCER, 2015, 87 : S25 - S26
  • [45] Adjuvant cisplatin chemotherapy should not be given in NSCLC
    Thatcher, N
    [J]. LUNG CANCER, 2004, 45 : S25 - S26
  • [46] Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLC
    Evans, WK
    [J]. ONCOLOGY-NEW YORK, 1998, 12 (03): : 18 - 26
  • [47] Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival
    Haigh, PI
    Ituarte, PHG
    Wu, HS
    Treseler, PA
    Posner, MD
    Quivey, JM
    Duh, QY
    Clark, OH
    [J]. CANCER, 2001, 91 (12) : 2335 - 2342
  • [48] A single institution experience of adjuvant chemotherapy for resected NSCLC
    Taylor, P.
    Benrajab, A.
    Summers, Y.
    Bishop, P.
    Shah, R.
    Thatcher, N.
    [J]. LUNG CANCER, 2010, 67 : S8 - S8
  • [49] A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective
    Barlesi, Fabrice
    Chouaid, Christos
    Crequit, Jacky
    Le Caer, Herve
    Pujol, Jean-Louis
    Legodec, Julien
    Vergnenegre, Alain
    Le Treut, Jacques
    Fabre-Guillevin, Elizabeth
    Loundou, Anderson
    Auquier, Pascal
    Simeoni, Marie-Claude
    Thomas, Pascal A.
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2015, 20 (06) : 783 - 790
  • [50] Adjuvant chemotherapy dose delivery for completely resected NSCLC in a regional cancer centre: analysis of outcomes by age and comorbidity
    Wood, S.
    Li, R.
    Beesley, S.
    Brown, J.
    Cominos, M.
    Hall, J.
    Sevitt, T.
    Shah, R.
    Taylor, H.
    Burcombe, R.
    [J]. LUNG CANCER, 2015, 87 : S26 - S26
12345